US2010291571A1PendingUtilityA1

Diagnosis of fetal aneuploidy by quantification of genomic dna from mixed samples

Assignee: ARTEMIS HEALTH INCPriority: Jun 14, 2006Filed: Mar 31, 2010Published: Nov 18, 2010
Est. expiryJun 14, 2026(expired)· nominal 20-yr term from priority
C12Q 2600/16C12Q 2600/156C12Q 1/6883C12Q 2600/158G16B 20/00G01N 1/30G16B 20/10G16B 20/20
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides systems, apparatuses, and methods to detect the presence of fetal cells when mixed with a population of maternal cells in a sample and to test fetal abnormalities, i.e. aneuploidy. In addition, the present invention provides methods to determine when there are insufficient fetal cells for a determination and report a non-informative case. The present invention involves quantifying regions of genomic DNA from a mixed sample. More particularly the invention involves quantifying DNA polymorphisms from the mixed sample.

Claims

exact text as granted — not AI-modified
1 . A method for diagnosing a fetal abnormality comprising:
 obtaining a maternal blood sample,   enriching one or more fetal cells from said sample using size-based separation,   analyzing one or more regions of genomic DNA from said fetal cells for STRs, and   determining a fetal abnormality based on the STR analysis.

Join the waitlist — get patent alerts

Track US2010291571A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.